SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: LLCF who wrote (2992)5/26/1999 10:27:00 AM
From: Don Miller  Read Replies (2) of 10280
 
This IgE blocker treatment was public domain information at least as far back as October Or November when I first saw a NBC Nightline report on the Tanox drug. The news was good for the inital treatment at that time, what was not covered was the sustainability of the treatment. They perform their action by disabling the autoimmune system, they need to appreciate the consequences of shutting down the autoimmune system.

NBC Nightline reran that same program again in about February.

This market should not be discounting for this issue, it is very old news.

According to our MD's here and on YC IgE Blockers are serious threat possibly ever, but no sooner than many years away.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News